4
Changes in Ownership
Arcadia Biosciences, Inc. Filed Acc 0001209191-19-047580
Chief Financial Officer acquired 8,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Plavan Matthew T Chief Financial Officer | 2019-08-26 | Grant or award | +1,000 | $8.33 | $8,330 | 1,000 | D |
| Plavan Matthew T Chief Financial Officer | 2019-08-26 | Grant or award | +1,000 | $9.22 | $9,220 | 2,000 | D |
| Plavan Matthew T Chief Financial Officer | 2019-08-27 | Grant or award | +1,000 | $9.32 | $9,320 | 3,000 | D |
| Plavan Matthew T Chief Financial Officer | 2019-08-27 | Grant or award | +1,000 | $9.30 | $9,300 | 4,000 | D |
| Plavan Matthew T Chief Financial Officer | 2019-08-27 | Grant or award | +1,000 | $8.95 | $8,950 | 5,000 | D |
| Plavan Matthew T Chief Financial Officer | 2019-08-27 | Grant or award | +2,000 | $8.93 | $17,860 | 7,000 | D |
| Plavan Matthew T Chief Financial Officer | 2019-08-28 | Grant or award | +1,000 | $6.88 | $6,880 | 8,000 | D |
Loading xslF345X03/doc4.xml…